Preclinical News and Research

RSS
Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

9 Jan 2012
Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals makes progress with its HCV development pipeline

9 Jan 2012
Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

9 Jan 2012
Presidio completes PPI-668 Phase 1a study on hepatitis C

Presidio completes PPI-668 Phase 1a study on hepatitis C

9 Jan 2012
JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

9 Jan 2012
BerGenBio completes $8.8M Series A financing round

BerGenBio completes $8.8M Series A financing round

9 Jan 2012
Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

9 Jan 2012
miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

9 Jan 2012
Silence completes siRNA research work with AstraZeneca, MedImmune

Silence completes siRNA research work with AstraZeneca, MedImmune

7 Jan 2012
Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

7 Jan 2012
Clearside Biomedical receives $4M venture capital investment

Clearside Biomedical receives $4M venture capital investment

6 Jan 2012
Celtaxsys announces acquisition of CTX-4430 from Estrellita

Celtaxsys announces acquisition of CTX-4430 from Estrellita

6 Jan 2012
Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

6 Jan 2012
CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

5 Jan 2012
Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

5 Jan 2012
Midatech raises £6.3M through private investment round

Midatech raises £6.3M through private investment round

5 Jan 2012
Novel vaccine combinations can protect against infection by SIV

Novel vaccine combinations can protect against infection by SIV

5 Jan 2012
Article focuses on new optical tools that use laser beams to peer painlessly below the skin

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

5 Jan 2012
Probiodrug secures EUR 15M for clinical development of PQ912

Probiodrug secures EUR 15M for clinical development of PQ912

5 Jan 2012
Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

5 Jan 2012

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback